Argent Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$2.35M Buy
29,256
+328
+1% +$27.1K 0.64% 51
2017
Q4
$2.34M Sell
28,928
-3,647
-11% -$292K 0.63% 49
2017
Q3
$2.53M Buy
32,575
+1,301
+4% +$108K 0.69% 44
2017
Q2
$2.78M Buy
31,274
+6,489
+26% +$547K 0.78% 39
2017
Q1
$2M Sell
24,785
-2,902
-10% -$227K 0.57% 56
2016
Q4
$1.97M Sell
27,687
-757
-3% -$59.5K 0.57% 55
2016
Q3
$2.46M Sell
28,444
-1,875
-6% -$163K 0.75% 40
2016
Q2
$2.63M Sell
30,319
-9,403
-24% -$760K 0.82% 34
2016
Q1
$2.98M Sell
39,722
-916
-2% -$69K 0.95% 30
2015
Q4
$3.13M Buy
+40,638
New +$3.06M 1.03% 28

Other funds holding MDT

Argent Trust's MDT Position: Q1 2018 in Review

Argent Trust increased its Medtronic (MDT) stake by 1.1% in Q1 2018, buying an estimated $27.1K and bringing the position to 29,256 shares worth $2.35M. The position accounts for 0.64% of the portfolio, ranked #51.

Argent Trust first reported a position in MDT in Q4 2015 and has held it in 10 quarters since. The position peaked at $3.13M in Q4 2015. 1,381 funds tracked by Wall St. Rank hold MDT as of Q1 2018.

  • Argent Trust held 29,256 shares of Medtronic worth $2.35M as of Q1 2018.
  • Argent Trust bought 328 Medtronic shares in Q1 2018, an estimated $27.1K.
  • Medtronic made up 0.64% of Argent Trust's portfolio in Q1 2018, its #51 holding.
  • Argent Trust first reported a position in Medtronic in Q4 2015 and has held it in 10 quarters since.
  • Argent Trust's Medtronic position peaked at $3.13M in Q4 2015.
  • 1,381 funds tracked by Wall St. Rank held Medtronic as of Q1 2018.

Based on Argent Trust's 13F filing for Q1 2018, filed 11 May 2018.